Springer Nature
Browse
40425_2018_467_MOESM2_ESM.docx (88.49 kB)

of A rare population of tumor antigen-specific CD4+CD8+ double-positive ιβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells

Download (88.49 kB)
Version 2 2019-10-24, 13:22
Version 1 2019-01-10, 04:51
journal contribution
posted on 2019-10-24, 13:22 authored by Junko Matsuzaki, Takemasa Tsuji, Thinle Chodon, Courtney Ryan, Richard Koya, Kunle Odunsi
of A rare population of tumor antigen-specific CD4+CD8+ double-positive ιβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells

Funding

Ovarian Cancer Research Fund

History

Usage metrics

    Springer Nature

    Categories

    Keywords

    NY-ESO-1TCR gene-engineeringCD4+CD8+ double-positive T cellsHLA-A*02:01Anti-tumor functionAdoptive cell therapyOvarian cancer

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC